Monterey Bio Acquisition Corporation
MTRY · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$0 | -$0 | $0 |
| % Margin | – | – | – |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -0.44 | -0.04 | -0 |
| % Growth | -989.1% | -4,208,233.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 |